Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""ADENOCARCINOMA"" wg kryterium: Temat


Starter badań:

Tytuł :
Clinicopathological characteristics and survival outcomes for patients with mucinous colorectal cancer liver metastases undergoing hepatic resection: A systematic review and meta-analysis.
Autorzy :
Reynolds IS; Department of Surgery, St Michael's Hospital, Co Dublin, Ireland; Department of Hepatobiliary and Liver Transplant Surgery, St Vincent's University Hospital, Dublin 4, Ireland. Electronic address: .
Cromwell PM; Department of Hepatobiliary and Liver Transplant Surgery, St Vincent's University Hospital, Dublin 4, Ireland.
Hoti E; Department of Surgery, St Michael's Hospital, Co Dublin, Ireland; Department of Hepatobiliary and Liver Transplant Surgery, St Vincent's University Hospital, Dublin 4, Ireland.
Pokaż więcej
Źródło :
American journal of surgery [Am J Surg] 2021 Sep; Vol. 222 (3), pp. 529-535. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Adenocarcinoma, Mucinous*/mortality
Adenocarcinoma, Mucinous*/pathology
Adenocarcinoma, Mucinous*/secondary
Adenocarcinoma, Mucinous*/surgery
Colonic Neoplasms*/mortality
Colonic Neoplasms*/pathology
Colonic Neoplasms*/secondary
Colonic Neoplasms*/surgery
Hepatectomy*
Rectal Neoplasms*/mortality
Rectal Neoplasms*/pathology
Rectal Neoplasms*/secondary
Rectal Neoplasms*/surgery
Liver Neoplasms/*mortality
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adenocarcinoma/secondary ; Adenocarcinoma/surgery ; Age Factors ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Databases, Factual ; Female ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/pathology ; Liver Neoplasms/secondary ; Liver Neoplasms/surgery ; Male ; Sex Factors
Czasopismo naukowe
Tytuł :
The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
Autorzy :
Ito H; Department of Thoracic Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan. .
Date H; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Shintani Y; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Miyaoka E; Department of Mathematics, Tokyo University of Science, Tokyo, Japan.
Nakanishi R; Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Kadokura M; Respiratory Disease Center, Showa University Northern Yokohama Hospital, Yokohama-shi, Japan.
Endo S; Department of Thoracic Surgery, Jichi Medical School, Shimotsuke, Japan.
Chida M; Department of General Thoracic Surgery, Dokkyo Medical University, Shimotsuga-gun, Japan.
Yoshino I; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Suzuki H; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Pokaż więcej
Corporate Authors :
Japanese Joint Committee of Lung Cancer Registry
Źródło :
BMC cancer [BMC Cancer] 2022 Aug 10; Vol. 22 (1), pp. 875. Date of Electronic Publication: 2022 Aug 10.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Adenocarcinoma*/surgery
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Adenocarcinoma of Lung*/surgery
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
ErbB Receptors/genetics ; Humans ; Japan/epidemiology ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Registries ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials.
Autorzy :
Liu DHW; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria.
Šefčovičová N; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.
Emmerson J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Spaans LN; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Surgery, Maxima Medical Centre, Eindhoven/Veldhoven, the Netherlands.
Saito Y; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Hutchins G; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Nankivell MG; Medical Research Council Clinical Trials Unit at University College London, London, UK.
Langley RE; Medical Research Council Clinical Trials Unit at University College London, London, UK.
Allum W; Department of Oncology and Department of Surgery, Royal Marsden NHS Foundation Trust, London, UK.
Cunningham D; Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, UK.
Langer R; Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria.
Grabsch HI; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jul; Vol. 170, pp. 140-148. Date of Electronic Publication: 2022 May 27.
Typ publikacji :
Clinical Trial, Phase III; Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma, Mucinous*/pathology
Esophageal Neoplasms*/pathology
Humans ; Mucins/therapeutic use ; Neoadjuvant Therapy ; Prognosis ; United Kingdom
SCR Disease Name :
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Tytuł :
Pathological and clinical features of multiple cancers and lung adenocarcinoma: a multicentre study.
Autorzy :
Bertoglio P; Division of Thoracic Surgery, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.
Ventura L; Division of Thoracic Surgery, University Hospital of Parma, Parma, Italy.
Aprile V; Division of Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.
Cattoni MA; Division of Thoracic Surgery, University of Insubria, Varese, Italy.
Nachira D; Department of General Thoracic Surgery, Fondazione Policlinico 'A. Gemelli'-Catholic University of Sacred Heart, Rome, Italy.
Lococo F; Department of General Thoracic Surgery, Fondazione Policlinico 'A. Gemelli'-Catholic University of Sacred Heart, Rome, Italy.
Rodriguez Perez M; Division of Thoracic Surgery, Clinica Universidad de Navarra, Madrid, Spain.
Guerrera F; Division of Thoracic Surgery, University of Torino, Torino, Italy.
Minervini F; Division of Thoracic Surgery. Cantonal Hospital Lucerne, Lucerne, Switzerland.
Gnetti L; Division of Pathological Anatomy, University Hospital of Parma, Parma, Italy.
Lenzini A; Division of Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.
Franzi F; Division of Pathological Anatomy, University of Insubria, Varese, Italy.
Querzoli G; Division of Pathological Anatomy, IRCCS Sacro Cuore Don Calabria Hospital, Verona, Italy.
Rindi G; Division of Pathological Anatomy, Fondazione Policlinico 'A. Gemelli'-Catholic University of Sacred Heart, Rome, Italy.
Bellafiore S; Division of Pathological Anatomy, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.
Femia F; Division of Thoracic Surgery, University of Torino, Torino, Italy.
Bogina GS; Division of Pathological Anatomy, IRCCS Sacro Cuore Don Calabria Hospital, Verona, Italy.
Bacchin D; Division of Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.
Kestenholz P; Division of Thoracic Surgery. Cantonal Hospital Lucerne, Lucerne, Switzerland.
Ruffini E; Division of Thoracic Surgery, University of Torino, Torino, Italy.
Paci M; Division of Thoracic Surgery, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.
Margaritora S; Department of General Thoracic Surgery, Fondazione Policlinico 'A. Gemelli'-Catholic University of Sacred Heart, Rome, Italy.
Imperatori AS; Division of Thoracic Surgery, University of Insubria, Varese, Italy.
Lucchi M; Division of Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.
Ampollini L; Division of Thoracic Surgery, University Hospital of Parma, Parma, Italy.
Terzi AC; Division of Thoracic Surgery, IRCCS Sacro Cuore Don Calabria Hospital, Verona, Italy.
Pokaż więcej
Źródło :
Interactive cardiovascular and thoracic surgery [Interact Cardiovasc Thorac Surg] 2022 Jun 15; Vol. 35 (1).
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/diagnosis
Lung Neoplasms*/epidemiology
Lung Neoplasms*/surgery
Humans ; Male ; Neoplasm Staging ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma.
Autorzy :
Orstad G; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.
Fort G; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.
Parnell TJ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Jones A; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Pathology, University of Utah, Salt Lake City, UT, USA.
Stubben C; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Lohman B; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Gillis KL; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.
Orellana W; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.
Tariq R; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Klingbeil O; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
Kaestner K; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Vakoc CR; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
Spike BT; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.
Snyder EL; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA; Department of Pathology, University of Utah, Salt Lake City, UT, USA. Electronic address: .
Pokaż więcej
Źródło :
Developmental cell [Dev Cell] 2022 Aug 08; Vol. 57 (15), pp. 1866-1882.e10. Date of Electronic Publication: 2022 Jul 13.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/genetics
Adenocarcinoma*/metabolism
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/metabolism
Animals ; Cell Transformation, Neoplastic ; Hepatocyte Nuclear Factor 3-alpha/genetics ; Hepatocyte Nuclear Factor 3-beta/genetics ; Humans ; Mice ; Thyroid Nuclear Factor 1
Czasopismo naukowe
Tytuł :
Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma.
Autorzy :
Ahn B; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Yoon S; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim D; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Chun SM; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Lee G; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim HR; Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Jin Jang S; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Sang Hwang H; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. Electronic address: .
Pokaż więcej
Źródło :
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2022 Aug; Vol. 170, pp. 176-184. Date of Electronic Publication: 2022 Jul 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/pathology
Genomics ; Humans ; Male ; Prognosis
Czasopismo naukowe
Tytuł :
MicroRNA-1-3p affects lung adenocarcinoma progression through E2F8 and regulating NF-кB pathway.
Autorzy :
Lin Q; Cardiothoracic Surgery, Puyang Oilfield General Hospital, China. Electronic address: .
Pokaż więcej
Źródło :
Cytokine [Cytokine] 2022 Aug; Vol. 156, pp. 155922. Date of Electronic Publication: 2022 Jun 01.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Liver Neoplasms*
Lung Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Humans ; NF-kappa B/genetics ; Repressor Proteins
Czasopismo naukowe
Tytuł :
Functional characterization and clinical significance of super-enhancers in lung adenocarcinoma.
Autorzy :
Jiang X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Qin N; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Hua T; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Wei X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Li Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Chen C; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Gong L; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Liu S; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Wang C; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.; Department of Bioinformatics, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing, China.
Yin R; Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Jiang Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Dai J; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Xu L; Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Shen H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.; Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing, China.
Ma H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.; Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2022 Aug; Vol. 61 (8), pp. 776-786. Date of Electronic Publication: 2022 May 21.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Adenocarcinoma*/metabolism
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Cohort Studies ; Gene Expression Regulation, Neoplastic ; Humans ; Transcription Factor AP-1/genetics
Czasopismo naukowe
Tytuł :
Deep exploration of immune function in EGFR wild-type and mutated lung adenocarcinomas by gene expression profiling: role of TRAIL-R2 (TNFRSF10B) in patient treatment and outcome.
Autorzy :
Chang WC; Institute of Clinical Medicine, National Yang Ming Chiao Tung University No. 155, Sec. 2, Linong St., Beitou District, Taipei, 112304, Taiwan; Department of Pathology, MacKay Memorial Hospital No. 92. Sec. 2, Zhongshan N. Road, Taipei, 104217, Taiwan; Department of Medicine, MacKay Medical College No. 42, Section 3, Zhongzheng Road, Sanzhi District, New Taipei City, 25245, Taiwan. Electronic address: .
Yeh YC; Division of Molecular Pathology, Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital No. 201, Sect 2, Shipai Rd., Beitou District, Taipei, 112201, Taiwan. Electronic address: .
Ho HL; Division of General Laboratory, Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital No. 201, Sect 2, Shipai Rd., Beitou District, Taipei, 112201, Taiwan. Electronic address: .
Chou TY; Institute of Clinical Medicine, National Yang Ming Chiao Tung University No. 155, Sec. 2, Linong St., Beitou District, Taipei, 112304, Taiwan; Division of Molecular Pathology, Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital No. 201, Sect 2, Shipai Rd., Beitou District, Taipei, 112201, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Human pathology [Hum Pathol] 2022 Aug; Vol. 126, pp. 9-18. Date of Electronic Publication: 2022 May 10.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Lung Neoplasms*/therapy
ErbB Receptors/genetics ; Gene Expression Profiling ; Humans ; Immunity ; Mutation ; Prognosis ; RNA, Messenger ; Receptors, TNF-Related Apoptosis-Inducing Ligand/genetics ; Treatment Outcome ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Co-expression patterns explain how a basic transcriptional role for MYC modulates Wnt and MAPK pathways in colon and lung adenocarcinomas.
Autorzy :
Kucherlapati MH; Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Cell cycle (Georgetown, Tex.) [Cell Cycle] 2022 Aug; Vol. 21 (15), pp. 1619-1638. Date of Electronic Publication: 2022 Apr 19.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/genetics
Adenomatous Polyposis Coli*
Colonic Neoplasms*/genetics
Colonic Neoplasms*/pathology
Lung Neoplasms*/genetics
Cyclin-Dependent Kinases ; Humans ; Proto-Oncogene Proteins B-raf ; Wnt Signaling Pathway/genetics
Czasopismo naukowe
Tytuł :
Impact of minimal solid and micropapillary components on invasive lung adenocarcinoma recurrence.
Autorzy :
Chen C; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Chen ZJ; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Li WJ; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Pan XF; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Wen YY; Department of Pathology, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Deng T; Department of Pathology, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Le HB; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Zhang YK; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Zhang BJ; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China. Electronic address: .
Pokaż więcej
Źródło :
Annals of diagnostic pathology [Ann Diagn Pathol] 2022 Aug; Vol. 59, pp. 151945. Date of Electronic Publication: 2022 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*
Lung Neoplasms*/pathology
Humans ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
A triple-classification for the evaluation of lung nodules manifesting as pure ground-glass sign: a CT-based radiomic analysis.
Autorzy :
Yu Z; Department of Radiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China.; School of Medicine, Xiamen University, Xiamen, Fujian Province, China.
Xu C; School of Medicine, Xiamen University, Xiamen, Fujian Province, China.
Zhang Y; Department of Radiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China.
Ji F; Department of Radiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China. .
Pokaż więcej
Źródło :
BMC medical imaging [BMC Med Imaging] 2022 Jul 27; Vol. 22 (1), pp. 133. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma in Situ*/pathology
Adenocarcinoma in Situ*/surgery
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Humans ; Hyperplasia/pathology ; Lung/pathology ; Neoplasm Invasiveness/pathology ; Retrospective Studies ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł :
Associations of IFT20 and GM130 protein expressions with clinicopathological features and survival of patients with lung adenocarcinoma.
Autorzy :
Li L; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Chen Y; Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Liao W; Department of Respiratory and Critical Care Medicine, Fifth Hospital in Wuhan, Wuhan, 430050, Hubei, China.
Yu Q; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Lin H; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Shi Y; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Zhang L; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Fu G; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Wang Z; Department of Basic Medicine, Medical College, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Li X; Department of Basic Medicine, Medical College, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Kong X; Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Zhou T; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China. .; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China. .
Qin L; Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2022 Jul 22; Vol. 22 (1), pp. 809. Date of Electronic Publication: 2022 Jul 22.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Autoantigens/*metabolism
Membrane Proteins/*metabolism
Biomarkers, Tumor/metabolism ; Carrier Proteins ; Humans ; Lymphatic Metastasis ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Tytuł :
Barrett's esophagus, towards improved clinical practice.
Autorzy :
Martínez-Domínguez SJ; Servicio de Aparato Digestivo, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España; Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, España.
Lanas Á; Servicio de Aparato Digestivo, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España; Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, España; CIBERehd., Madrid, España; Facultad de Medicina, Universidad de Zaragoza, Zaragoza, España.
Domper-Arnal MJ; Servicio de Aparato Digestivo, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España; Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, España; CIBERehd., Madrid, España. Electronic address: .
Pokaż więcej
Transliterated Title :
Esófago de Barrett, hacia la mejora de la práctica clínica.
Źródło :
Medicina clinica [Med Clin (Barc)] 2022 Jul 22; Vol. 159 (2), pp. 92-100. Date of Electronic Publication: 2022 May 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Adenocarcinoma*/diagnosis
Adenocarcinoma*/epidemiology
Adenocarcinoma*/surgery
Barrett Esophagus*/diagnosis
Barrett Esophagus*/epidemiology
Barrett Esophagus*/therapy
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/surgery
Precancerous Conditions*/diagnosis
Precancerous Conditions*/pathology
Precancerous Conditions*/surgery
Biopsy ; Esophagoscopy ; Humans ; Hyperplasia
SCR Disease Name :
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Tytuł :
Outcomes of patients with different lepidic percentage and tumor size of stage I lung adenocarcinoma.
Autorzy :
Liu C; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Wang LC; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chen HS; Department of Health Care Administration, Chang Jung Christian University, Tainan City, Taiwan.
Yeh YC; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsu PK; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, National Yang-Ming Chiao Tung University, Taiwan.
Huang CS; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, National Yang-Ming Chiao Tung University, Taiwan.
Hsieh CC; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, National Yang-Ming Chiao Tung University, Taiwan.
Hsu HS; Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, National Yang-Ming Chiao Tung University, Taiwan.
Pokaż więcej
Źródło :
Thoracic cancer [Thorac Cancer] 2022 Jul; Vol. 13 (14), pp. 2005-2013. Date of Electronic Publication: 2022 Jun 09.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Adenocarcinoma of Lung*/surgery
Lung Neoplasms*/pathology
Humans ; Neoplasm Invasiveness/pathology ; Neoplasm Staging ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma.
Autorzy :
Li Z; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wu W; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pan X; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Li F; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhu Q; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
He Z; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chen L; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło :
Cancer medicine [Cancer Med] 2022 Jul; Vol. 11 (14), pp. 2855-2864. Date of Electronic Publication: 2022 Mar 14.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*
Lung Neoplasms*/pathology
Antigens, Neoplasm ; Biomarkers, Tumor ; Carcinoembryonic Antigen ; Humans ; Keratin-19 ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
Autorzy :
Sánchez-Cuerda C; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.
Cuadra M; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.
Gámir S; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Lobo P; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Elices M; Department of Pathology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Cabrera Y; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Pokaż więcej
Źródło :
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2022 Jul; Vol. 158 (1), pp. 21-26. Date of Electronic Publication: 2021 Oct 23.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Adenocarcinoma*/diagnosis
Adenocarcinoma*/surgery
Adenocarcinoma in Situ*/surgery
Cervical Intraepithelial Neoplasia*/diagnosis
Uterine Cervical Neoplasms*/diagnosis
Uterine Cervical Neoplasms*/surgery
Adult ; Conization/methods ; Female ; Humans ; Pregnancy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Visceral obesity is associated with an increased risk of developing esophago-gastric junctional adenocarcinoma in Japan: a population-based case-control study in Akita Prefecture.
Autorzy :
Watanabe K; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan. .
Koizumi S; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
Shirane K; Shirane Hospital, Akita, Japan.
Tsuda H; Department of Gastroenterology, Akita Kousei Medical Center, Akita, Japan.
Watanabe H; Department of Gastroenterology, Akita Kousei Medical Center, Akita, Japan.
Tsuji T; Department of Gastroenterology, Akita City Hospital, Akita, Japan.
Onochi K; Department of Gastroenterology, Omagari Kosei Medical Center, Akita, Japan.
Yamai K; Department of Gastroenterology, Odate Municipal General Hospital, Akita, Japan.
Kusano C; Department of Gastroenterology, Yuri Kumiai General Hospital, Akita, Japan.; Department of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan.
Dohmen T; Department of Gastroenterology, Yuri Kumiai General Hospital, Akita, Japan.
Horikawa Y; Department of Gastroenterology, Hiraka General Hospital, Akita, Japan.
Ajimine T; Department of Gastroenterology, Northern Akita Municipal Hospital, Akita, Japan.
Saito M; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Koike T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Masamune A; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Shimodaira Y; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
Matsuhashi T; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
Iijima K; Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
Pokaż więcej
Źródło :
Esophagus : official journal of the Japan Esophageal Society [Esophagus] 2022 Jul; Vol. 19 (3), pp. 477-485. Date of Electronic Publication: 2022 Jan 06.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/epidemiology
Adenocarcinoma*/etiology
Stomach Neoplasms*/complications
Stomach Neoplasms*/etiology
Aged ; Body Mass Index ; Case-Control Studies ; Humans ; Japan/epidemiology ; Male ; Obesity/complications ; Obesity/epidemiology ; Obesity, Abdominal/complications ; Obesity, Abdominal/epidemiology
Czasopismo naukowe
Tytuł :
Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
Autorzy :
Hu LT; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Deng WJ; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Chu ZS; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Sun L; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; First Affiliated Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Zhang CB; Department of Medical Technology, Collaborative Innovation Center for Translation Medical Testing and Application Technology Zhangzhou, Zhang Zhou Health Vocational College, Zhangzhou, 363000, Fujian Province, China.
Lu SZ; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Weng JR; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; Stomatological Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Ren QS; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; Stomatological Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Dong XY; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Li WD; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Li XB; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; First Affiliated Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Du YT; Department of Laboratory, Cancer Hospital of China Medical University, Shenyang,, Liaoning Province, China.
Li Y; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China. .; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China. .
Wang WQ; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China. .; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China. .
Pokaż więcej
Źródło :
BMC pulmonary medicine [BMC Pulm Med] 2022 Jun 29; Vol. 22 (1), pp. 259. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł :
E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry.
Autorzy :
Du K; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Sun S; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Jiang T; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Liu T; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Zuo X; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Xia X; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Liu X; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Wang Y; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Bu Y; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Pokaż więcej
Źródło :
International journal of biological sciences [Int J Biol Sci] 2022 Jun 25; Vol. 18 (10), pp. 4151-4170. Date of Electronic Publication: 2022 Jun 25 (Print Publication: 2022).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/metabolism
Lung Neoplasms*/metabolism
E2F2 Transcription Factor/*metabolism
Animals ; Gene Expression Regulation ; Gene Expression Regulation, Neoplastic/genetics ; Mice ; Transcription Factors/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies